CD4 and HIV-1 infection: Since IFN-I pre-treatment limited HIV-1 infection in WT primary human CD4+ T cells (Fig 3C and 3D), and to a greater extent in ISG15KO cells, upregulation of a combination of differentially expressed genes is likely responsible for the HIV-1 resistance demonstrated here.